Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of EUR 94.39 billion. The enterprise value is 112.23 billion.

Market Cap	94.39B
Enterprise Value	112.23B

Important Dates

The next estimated earnings date is Tuesday, August 19, 2025.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Current Share Class	1.28B
Shares Outstanding	n/a
Shares Change (YoY)	-3.03%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.28B

Valuation Ratios

The trailing PE ratio is 23.01 and the forward PE ratio is 15.49.

PE Ratio	23.01
Forward PE	15.49
PS Ratio	3.20
PB Ratio	2.22
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.95, with an EV/FCF ratio of 24.60.

EV / Earnings	27.36
EV / Sales	3.91
EV / EBITDA	13.95
EV / EBIT	20.51
EV / FCF	24.60

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.61.

Current Ratio	1.85
Quick Ratio	1.20
Debt / Equity	0.61
Debt / EBITDA	3.15
Debt / FCF	5.71
Interest Coverage	8.78

Financial Efficiency

Return on equity (ROE) is 9.51% and return on invested capital (ROIC) is 5.19%.

Return on Equity (ROE)	9.51%
Return on Assets (ROA)	4.41%
Return on Invested Capital (ROIC)	5.19%
Return on Capital Employed (ROCE)	8.13%
Revenue Per Employee	310,659
Profits Per Employee	43,185
Employee Count	95,000
Asset Turnover	0.37
Inventory Turnover	2.17

Taxes

In the past 12 months, Medtronic has paid 823.68 million in taxes.

Income Tax	823.68M
Effective Tax Rate	16.63%

Stock Price Statistics

The stock price has decreased by -1.40% in the last 52 weeks. The beta is 0.82, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	-1.40%
50-Day Moving Average	74.66
200-Day Moving Average	80.44
Relative Strength Index (RSI)	44.72
Average Volume (20 Days)	981

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.07

Income Statement

In the last 12 months, Medtronic had revenue of EUR 29.51 billion and earned 4.10 billion in profits. Earnings per share was 3.18.

Revenue	29.51B
Gross Profit	19.30B
Operating Income	5.63B
Pretax Income	4.95B
Net Income	4.10B
EBITDA	8.02B
EBIT	5.63B
Earnings Per Share (EPS)	3.18

Full Income Statement

Balance Sheet

The company has 7.89 billion in cash and 26.07 billion in debt, giving a net cash position of -18.17 billion.

Cash & Cash Equivalents	7.89B
Total Debt	26.07B
Net Cash	-18.17B
Net Cash Per Share	n/a
Equity (Book Value)	42.47B
Book Value Per Share	32.97
Working Capital	9.62B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.20 billion and capital expenditures -1.64 billion, giving a free cash flow of 4.56 billion.

Operating Cash Flow	6.20B
Capital Expenditures	-1.64B
Free Cash Flow	4.56B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 65.39%, with operating and profit margins of 19.09% and 13.90%.

Gross Margin	65.39%
Operating Margin	19.09%
Pretax Margin	16.78%
Profit Margin	13.90%
EBITDA Margin	27.17%
EBIT Margin	19.09%
FCF Margin	15.46%

Dividends & Yields

This stock pays an annual dividend of 2.60, which amounts to a dividend yield of 3.55%.

Dividend Per Share	2.60
Dividend Yield	3.55%
Dividend Growth (YoY)	2.34%
Years of Dividend Growth	1
Payout Ratio	76.98%
Buyback Yield	3.03%
Shareholder Yield	6.58%
Earnings Yield	4.35%
FCF Yield	4.83%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.74 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.74
Piotroski F-Score	5